The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

Fluorescent protein fusions have been a popular means ... 2005). They labeled a transferrin receptor–PCP fusion and its ligand, transferrin, with Alexa fluorophores, which allowed them to ...

OCU200 is a recombinant fusion protein that comprises tumstatin ... agent by targeting integrin receptors while transferrin aims the drug towards the choroid and retina via transferrin receptors ...